Search

everythinglearnresearchcommunity

for

Search:↓

Auto-portraits help evaluate scalp hair.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Most women with polycystic ovary syndrome (PCOS) have menstrual issues, infertility, acne, and excessive body hair, with the most common type being the non-androgenic phenotype.

The book provides a detailed guide on managing Polycystic Ovary Syndrome and is useful for physicians.

Metformin helps induce ovulation in obese women with PCOS, but weight loss is still the main treatment.

PCOS affects many aspects of health, not just fertility, and needs comprehensive treatment.

Early diagnosis and treatment of PCOS are crucial to reduce health risks and costs.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

PCOS prevalence varies by ethnicity and location due to inconsistent diagnosis and limited research.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

The questionnaire is valid and reliable but needs more testing for future predictions.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

Metformin helps manage PCOS by improving fertility and is safe for pregnancy, especially when combined with certain treatments.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Obese and lean women with PCOS have different symptoms and need different treatments.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

People with reproductive, thyroid disorders, and type 2 diabetes can experience voice changes, but more research is needed to understand this better.

Ultrasound and Doppler analysis are valuable tools for diagnosing and understanding polycystic ovary syndrome.

PCOS is linked to obesity and inflammation, increasing cardiovascular risk.